Quest Diagnostics Incorporated (BIT:1QDX)

Market Cap	16.97B
Revenue (ttm)	9.25B
Net Income (ttm)	820.76M
Shares Out	n/a
EPS (ttm)	7.26
PE Ratio	20.68
Forward PE	16.75
Dividend	2.91 (1.85%)
Ex-Dividend Date	Oct 2, 2025

Volume	n/a
Average Volume	5
Open	157.50
Previous Close	157.50
Day's Range	157.50 - 157.50
52-Week Range	141.74 - 171.05
Beta	n/a
RSI	43.83
Earnings Date	Feb 2, 2026

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans,...

• Industry: Medical Laboratories
• Founded: 1967
• Employees: 56,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1QDX

Financial Performance

In 2024, Quest Diagnostics's revenue was $9.87 billion, an increase of 6.70% compared to the previous year's $9.25 billion. Earnings were $866.00 million, an increase of 1.88%.

Financial numbers in USD